The Race to Manufacture COVID-19 Vaccines: Emerging Vaccine Technologies

THE RACE TO MANUFACTURE COVID-19 VACCINES

EMERGING VACCINE TECHNOLOGIES

NOVEMBER 2023

Creative Commons Attribution 3.0 IGO license (CC BY 3.0 IGO)

© 2023 Asian Development Bank

6 ADB Avenue, Mandaluyong City, 1550 Metro Manila, Philippines

Tel +63 2 8632 4444; Fax +63 2 8636 2444

www.adb.org

Some rights reserved. Published in 2023.

ISBN 978-92-9270-481-0 (print); 978-92-9270-482-7 (electronic); 978-92-9270-483-4 (ebook)

Publication Stock No. TCS230556-2

DOI: http://dx.doi.org/10.22617/TCS230556-2

The views expressed in this publication are those of the authors and do not necessarily reflect the views and policies of the Asian Development Bank (ADB) or its Board of Governors or the governments they represent.

ADB does not guarantee the accuracy of the data included in this publication and accepts no responsibility for any consequence of their use. The mention of specific companies or products of manufacturers does not imply that they are endorsed or recommended by ADB in preference to others of a similar nature that are not mentioned.

By making any designation of or reference to a particular territory or geographic area, or by using the term country in this publication, ADB does not intend to make any judgments as to the legal or other status of any territory or area.

This publication is available under the Creative Commons Attribution 3.0 IGO license (CC BY 3.0 IGO) https://creativecommons.org/licenses/by/3.0/igo/. By using the content of this publication, you agree to be bound by the terms of this license. For attribution, translations, adaptations, and permissions, please read the provisions and terms of use at https://www.adb.org/terms-use#openaccess.

This CC license does not apply to non-ADB copyright materials in this publication. If the material is attributed to another source, please contact the copyright owner or publisher of that source for permission to reproduce it. ADB cannot be held liable for any claims that arise as a result of your use of the material.

Please contact [email protected] if you have questions or comments with respect to content, or if you wish to obtain copyright permission for your intended use that does not fall within these terms, or for permission to use the ADB logo.

Corrigenda to ADB publications may be found at http://www.adb.org/publications/corrigenda.

Notes:

In this publication, $ refers to United States dollars.

ADB recognizes America as the United States and China as the People’s Republic of China.

This study was prepared by the Therapeutic Goods Administration (TGA) for the Asian Development Bank (ADB). The information provided is advice only for the purposes of investment and procurement decision-making in emerging vaccine technology for infectious diseases (including COVID-19). It represents a summary of literature-based analysis and scientific evaluation. Some of the data and opinions presented in this document are derived from information provided by the relevant companies and have not always been subject to independent validation. This information is not an authorization, warranty, or guarantee of any therapeutic good. The Australian Government is not responsible for negligence or otherwise in any injury, loss, or damage however arising from the use of, or reliance on, the information provided.

Suggested citation:

P. Papathanasiou, P. Osewe, M. Apostol, and B. Coghlan, eds. 2023. The Race to Manufacture COVID-19 Vaccines—Emerging Vaccine Technologies. Manila: ADB.

Cover design by Claudette Rodrigo.

Contents

Tables and Figure

Abbreviations